INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 203 filers reported holding INSMED INC in Q2 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,817,426 | +19.7% | 1,339,304 | 0.0% | 2.50% | +14.4% |
| Q2 2023 | $28,259,314 | +23.8% | 1,339,304 | 0.0% | 2.18% | +44.9% |
| Q1 2023 | $22,835,133 | +36.1% | 1,339,304 | +59.4% | 1.51% | +43.8% |
| Q4 2022 | $16,783,200 | +1.2% | 840,000 | +9.1% | 1.05% | +32.5% |
| Q3 2022 | $16,586,000 | +9.2% | 770,000 | 0.0% | 0.79% | +5.7% |
| Q2 2022 | $15,184,000 | -8.5% | 770,000 | +9.1% | 0.75% | -14.5% |
| Q1 2022 | $16,587,000 | -12.5% | 705,838 | +1.4% | 0.88% | -2.6% |
| Q4 2021 | $18,955,000 | -1.1% | 695,840 | 0.0% | 0.90% | -9.4% |
| Q3 2021 | $19,163,000 | -3.2% | 695,840 | 0.0% | 0.99% | +12.9% |
| Q2 2021 | $19,804,000 | +27.3% | 695,840 | +52.4% | 0.88% | +36.8% |
| Q1 2021 | $15,553,000 | +8.6% | 456,631 | +6.2% | 0.64% | +4.6% |
| Q4 2020 | $14,318,000 | +3.6% | 430,107 | 0.0% | 0.61% | -10.5% |
| Q3 2020 | $13,824,000 | +16.7% | 430,107 | 0.0% | 0.69% | -10.3% |
| Q2 2020 | $11,845,000 | – | 430,107 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |